TAMPA, FL & MINNEAPOLIS--(BUSINESS WIRE)--Biovest International, Inc. (OTCQB:BVTI), a majority-owned subsidiary of Accentia Biopharmaceuticals, Inc. (OTCQB:ABPI), today announced the international members of its Scientific Advisory Board (SAB) comprised of key opinion leaders from prestigious institutions such as the Sunnybrook-Odette Cancer Centre at the University of Toronto, University of Cologne and University of Nottingham. Dedicated to the advancement of cancer vaccines, the Biovest SAB represents a group of preeminent physicians and doctors from the fields of cancer immunotherapy, immunology, regulatory affairs, bioinformatics and cell culture bio-manufacturing.
